tiprankstipranks
Advertisement
Advertisement
NeoGenomics price target raised to $16 from $11 at BofA
PremiumThe FlyNeoGenomics price target raised to $16 from $11 at BofA
20d ago
NeoGenomics launches FDA-approved PTEN IHC prostate Cancer ompanion diagnostic
Premium
The Fly
NeoGenomics launches FDA-approved PTEN IHC prostate Cancer ompanion diagnostic
24d ago
NeoGenomics Adds Data-Focused Independent Director to Board
Premium
Company Announcements
NeoGenomics Adds Data-Focused Independent Director to Board
1M ago
NeoGenomics Launches Convertible Notes Offering and Repurchase Plan
PremiumCompany AnnouncementsNeoGenomics Launches Convertible Notes Offering and Repurchase Plan
2M ago
NeoGenomics files to sell $275M of convertible senior notes due 2032
Premium
The Fly
NeoGenomics files to sell $275M of convertible senior notes due 2032
2M ago
NeoGenomics Shareholders Approve Expanded Equity Incentive Plan
Premium
Company Announcements
NeoGenomics Shareholders Approve Expanded Equity Incentive Plan
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100